During the recent years it has been shown that transarterial applications of anticancer agents are promising approaches in the treatment of hepatic malignancies. While new techniques led to a reappraisal of hepatic arterial infusion chemotherapy (HAIC) over implanted port systems, there has also been a growing interest in the use of transarterial radioembolization (RE). The concept of transarterial regional oncologic treatment of hepatic malignancies presupposes that the entire liver can be exclusively treated over the supplying arteries. Several imaging modalities are in use for prediction and control of per-fusion territories of intraarterial catheters. Besides digital subtraction angiography (DSA), computed tomography (CT) and magnetic resonance imaging (MRI), scin-tigraphic imaging is being employed to visualize the intrahepatic perfusion pattern, to exclude extrahepatic perfusion, and to assess an intrahepatic arteriovenous shunting to the lung. In the following, the current status of HAIC and RE in cancer therapy, the application techniques and the use of different imaging modalities, especially single photon emission computed tomography (SPECT) and SPECT with integrated computed tomography (SPECT-CT), for planning and control of treatment will be discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Amthauer, H., Denecke, T., Rohlfing, T., Ruf, J., Bohmig, M., Gutberlet, M., Plockinger, U., Felix, R., and Lemke, A.J. 2005. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur. Radiol. 15: 1456–1462.
Andrews, J.C., Walker, S.C., Ackermann, R.J., Cotton, L.A., Ensminger, W.D., and Shapiro, B. 1994. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J. Nucl. Med. 35: 1637–1644.
Bocher, M., Balan, A., Krausz, Y., Shrem, Y., Lonn, A., Wilk, M., and Chisin, R. 2000. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur. J. Nucl. Med. 27: 619–627.
Campbell, A.M., Bailey, I.H., and Burton, M.A. 2001. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys. Med. Biol. 46: 487–498.
Cantore, M., Mambrini, A., Fiorentini, G., Rabbi, C., Zamagni, D., Caudana, R., Pennucci, C., Sanguinetti, F., Lombardi, M., and Nicoli, N. 2005. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluor-ouracil in patients with unresectable biliary tract tumors. Cancer 103: 1402–1407.
Cohen, A.D., and Kemeny, N.E. 2003. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 8: 553–566.
Dancey, J.E., Shepherd, F.A., Paul, K., Sniderman, K.W., Houle, S., Gabrys, J., Hendler, A.L., and Goin, J.E. 2000. Treatment of nonresect-able hepatocellular carcinoma with intra-hepatic 90Y-microspheres. J. Nucl. Med. 41: 1673–1681.
Denecke, T., Hildebrandt, B., Lehmkuhl, L., Peters, N., Nicolaou, A., Pech, M., Riess, H., Ricke, J., Felix, R., and Amthauer, H. 2005. Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur. J. Nucl. Med. Mol. Imaging 32(9): 1003–1010.
Gray, B., Van Hazel, G., Hope, M., Burton, M., Moroz, P., Anderson, J., and Gebski, V. 2001. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann. Oncol. 12: 1711–1720.
Heinrich, S., Petrowsky, H., Schwinnen, I., Staib-Sebler, E., Gog, C., El-Ganainy, A., Gutt, C., Muller, H.H., and Lorenz, M. 2003. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluor-ouracil for colorectal liver metastases. Surgery 133: 40–48.
Kemeny, N., Huang, Y., Cohen, A.M., Shi, W., Conti, J.A., Brennan, M.F., Bertino, J.R., Turnbull, A.D., Sullivan, D., Stockman, J., Blumgart, L.H., and Fong, Y. 1999. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 341: 2039–2048.
Kerr, D.J., McArdle, C.S., Ledermann, J., Taylor, I., Sherlock, D.J., Schlag, P.M., Buckels, J., Mayer, D., Cain, D., and Stephens, R.J. 2003. Medical Research Council's colorectal cancer study group; European Organisation for Research and Treatment of Cancer colorectal cancer study group. Intrahepatic arterial versus intravenous fluor-ouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 361: 368–373.
Lehner, K., Reiser, M., Gebhardt, U., Heuck, A., and Schaff, J. 1987. DSA — control of implanted devices for arterial hepatic perfusion. Cardiovasc. Intervent. Radiol. 10: 71–74.
Liu, D.M., Salem, R., Bui, J.T., Courtney, A., Barakat, O., Sergie, Z., Atassi, B., Barrett, K., Gowland, P., Oman, B., Lewandowski, R.J., Gates, V.L., Thurston, K.G., and Wong, C.Y. 2005. Angiographic considerations in patients undergoing liver-directed therapy. J. Vasc. Interv. Radiol. 16: 911–935.
Lorenz, M., and Muller, H.H. 2000. Randomized, multicenter trial of fluorouracil plus leucov-orin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyurid-ine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J. Clin. Oncol. 18: 243–254.
Lubin, E., Cyjon, A., and Neuman, M. 1987. Technetium-99m macroaggregates for the study of the distribution of arterial infusion chemotherapy in the liver. Clin. Nucl. Med. 12: 385–388.
Meta-Analysis Group in Cancer (MAGC). 1996. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J. Natl. Cancer Inst. 88: 252–258.
Morimoto, M., Satake, M., Sekiguchi, R., Haruno, M., and Moriyama, N. 1999. Optimal injection protocol for CT evaluation during hepatic arterial infusion chemotherapy. Invest. Radiol. 34: 744–750.
Murthy, R., Nunez, R., Szklaruk, J., Erwin, W., Madoff, D.C., Gupta, S., Ahrar, K., Wallace, M.J., Cohen, A., Coldwell, D.M., Kennedy, A.S., and Hicks, M.E. 2005. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25(1): S41–S55.
Nelson, R.L., and Freels, S. 2004. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver. Dis. Colon Rectum. 47: 739–745.
Pelosi, E., Bar, F., Battista, S., Bello, M., Bucchi, M.C., Alabiso, O., Molino, G., and Bisi, G. 1999. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach. Cancer Chemother. Pharmacol. 44: 505–510.
Ricke, J., Hildebrandt, B., Miersch, A., Nicolaou, A., Warschewske, G., Teichgraber, U., Lopez Hanninen, E., Riess, H., and Felix, R. 2004. Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events. J. Vasc. Interv. Radiol. 15: 825–833.
Sadahiro, S., Suzuki, T., Ishikawa, K., Yasuda, S., Tajima, T., Makuuchi, H., Saitoh, T., and Murayama, C. 2004. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Cancer 100: 590–597.
Seki, H., Ozaki, T., Takaki, S., Ooi, H., Oda, J., and Shiina, M. 2003. Using slow-infusion MR arteriography and an implantable port system to assess drug distribution at hepatic arterial infusion chemotherapy. AJR Am. J. Roentgenol. 180: 681–686.
Suzuki, Y., Kobayashi, S., and Yasuda, S. 1991. Application of single-photon emission computed tomography (SPECT) with 99mTc-MAA in evaluation of perfusion patterns during hepatic infusion chemotherapy. Ann. Nucl. Med. 5: 123–126.
Tanaka, S., Shimada, M., Shirabe, K., Maehara, S., Harimoto, N., Tsujita, E., Sugimachi, K., and Maehara, Y. 2005. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Hepatogastroenterology 52: 862–865.
Van Hazel, G., Blackwell, A., Anderson, J., Price, D., Moroz, P., Bower, G., Cardaci, G., and Gray, B. 2004 Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J. Surg. Oncol. 88: 78–85.
Ziessman, H.A., Gyves, J.W., Juni, J.E., Wahl, F.L., Thrall, J.H., Ensminger, W.D., Goldstein, H.A., and Dubiansky, V. 1985. Atlas of hepatic arterial perfusion scintigraphy. Clin. Nucl. Med. 10: 675–681.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V.
About this chapter
Cite this chapter
Denecke, T., Hildebrandt, B., Lopez-Hänninen, E. (2009). Perfusion Scintigraphy with Integrated Single Photon Emission Computed Tomography/Computed Tomography in the Management of Transarterial Treatment of Hepatic Malignancies. In: Hayat, M.A. (eds) Liver Cancer. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9804-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4020-9804-8_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-9803-1
Online ISBN: 978-1-4020-9804-8
eBook Packages: MedicineMedicine (R0)